Dolan Sondhi

Dolan Sondhi serves as a Professor of Research at Weill Cornell Medicine since February 1999, focusing on the clinical development of gene therapy for Batten disease and leading initiatives in intracranial gene transfer using adeno-associated virus (AAV). Other roles at Weill Cornell include Associate Director of the Belfer Gene Therapy Core Facility, where Dolan collaborates on GMP production and regulatory submissions, and previously held positions as Associate Professor, Manager of GMP Production, and Assistant Professor. Dolan is currently a member of the Scientific Advisory Board for Intelisci and Form Bio, and serves on the Board of Directors for Passage Bio. Additionally, Dolan has provided expertise as a Council Member for GLG and an Advisor for Guidepoint, with previous consulting experience at Defined Health and as a Post-Doctoral Associate at Rockefeller University, where significant advancements in protein engineering were made. Educational credentials include a Ph.D. in Chemistry from Brown University and a Bachelor of Science in Chemistry from St. Stephen's College, Delhi.